Home Newsfeeds Sidoti & Co. Upgrades HNI to Buy, Announces $34 Price Target

Sidoti & Co. Upgrades HNI to Buy, Announces $34 Price Target

Sidoti & Co. analyst Gregory Burns upgrades HNI (NYSE:HNI) from Neutral to Buy and announces $34 price target.

byBenzinga Newsdesk

March 9, 2023

1 minute read

Sidoti & Co. analyst Gregory Burns upgrades HNI (NYSE:HNI) from Neutral to Buy and announces $34 price target.

QIAGEN Expands Range Of Digital PCR Kits And Services For The Biopharma Industry

By Happy Mohamed

July 18, 4:15 PM

QIAGEN (NYSE:QGEN, Frankfurt Prime Standard: QIA)))) announced today the expansion of its digital PCR (dPCR) offering for the development of cell and gene therapies in the biopharma industry. The company has partnered

QGEN

$100 Invested In Old Dominion Freight Line 10 Years Ago Would Be Worth This Much Today

By Benzinga Insights

June 22, 4:30 PM

Old Dominion Freight Line (NASDAQ:ODFL) has outperformed the market over the past 10 years by 17.63% on an…

ODFL

Pieris Pharmaceuticals Announces Presentation Of Encouraging Preclinical Data For PRS-400 At ATS 2023 International Conference

By Benzinga Newsdesk

May 22, 8:10 AM

Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology platform for respiratory diseases, cancer, and other

PIRS